| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A comparative trial of risedronate vs. etidronate in the treatment of patients with Paget’s disease of bone
|
Miller, P.D
|
|
1999
|
24 |
5S1 |
p. 93S-
1 p.
|
article
|
| 2 |
A marker for type I collagen degradation identified in urine from patients with Paget’s disease of bone
|
Krane, S.M
|
|
1999
|
24 |
5S1 |
p. 52S-
1 p.
|
article
|
| 3 |
A multicenter study of chromosome 18q linkage in familial Paget’s disease
|
Hocking, L.J
|
|
1999
|
24 |
5S1 |
p. 31S-
1 p.
|
article
|
| 4 |
A new radioimmunoassay for C-terminal telopeptide of type I collagen in the diagnosis and follow-up of Paget’s disease
|
Gonnelli, S
|
|
1999
|
24 |
5S1 |
p. 52S-
1 p.
|
article
|
| 5 |
Animal-related risk factors in Spanish patients with Paget’s disease of bone
|
Morales-Piga, A
|
|
1999
|
24 |
5S1 |
p. 15S-
1 p.
|
article
|
| 6 |
A randomized treatment trial of intravenous pamidronate and oral alendronate in Paget’s disease: early results
|
Gutteridge, D.H
|
|
1999
|
24 |
5S1 |
p. 67S-68S
nvt p.
|
article
|
| 7 |
Are paramyxoviruses involved in paget’s disease? A negative view
|
Ralston, S.H
|
|
1999
|
24 |
5S1 |
p. 17S-18S
nvt p.
|
article
|
| 8 |
Biochemical markers of bone turnover in Paget’s disease of bone
|
Eastell, R
|
|
1999
|
24 |
5S1 |
p. 49S-50S
nvt p.
|
article
|
| 9 |
Biochemical markers of bone turnover in predicting response to clodronate therapy in Paget’s disease
|
Parker, C.R.
|
|
1999
|
24 |
5S1 |
p. 68S-
1 p.
|
article
|
| 10 |
Calcitonin, an update
|
Martin, T.J
|
|
1999
|
24 |
5S1 |
p. 63S-65S
nvt p.
|
article
|
| 11 |
Cellular and molecular regulation of bone turnover
|
Mundy, G.R
|
|
1999
|
24 |
5S1 |
p. 35S-38S
nvt p.
|
article
|
| 12 |
Demonstration of canine distemper virus in pagetic bone: possible explanation for failure to detect viruses using reverse transcriptase-polymerase chain reaction
|
Dixon, J.A
|
|
1999
|
24 |
5S1 |
p. 27S-
1 p.
|
article
|
| 13 |
Direct identification of osteoblast progenitor cells in Paget’s disease
|
Joyner, C.J
|
|
1999
|
24 |
5S1 |
p. 41S-
1 p.
|
article
|
| 14 |
Editorial
|
|
|
1999
|
24 |
5S1 |
p. I-II
nvt p.
|
article
|
| 15 |
Editorial
|
|
|
1999
|
24 |
5S1 |
p. III-
1 p.
|
article
|
| 16 |
Epidemiological, clinical, biochemical, and imaging characteristics of monostotic and polyostotic Paget’s disease
|
Monfort, J
|
|
1999
|
24 |
5S1 |
p. 13S-14S
nvt p.
|
article
|
| 17 |
Epidemiology of Paget’s disease of bone
|
Cooper, C
|
|
1999
|
24 |
5S1 |
p. 3S-5S
nvt p.
|
article
|
| 18 |
Failure to detect paramyxovirus RNA in bone and osteoblast-like and osteoclast-like cells cultured from patients with Paget’s disease
|
Ooi, C.G
|
|
1999
|
24 |
5S1 |
p. 27S-
1 p.
|
article
|
| 19 |
Family history and heritability of Paget’s disease: a multicenter study
|
Slee, F.
|
|
1999
|
24 |
5S1 |
p. 32S-
1 p.
|
article
|
| 20 |
Genetic epidemiology of Paget’s disease of bone in Eastern Québec
|
Brown, J.P
|
|
1999
|
24 |
5S1 |
p. 15S-
1 p.
|
article
|
| 21 |
Genetic linkage of Paget’s disease to chromosome 18q in a French pedigree
|
Lucotte, G.
|
|
1999
|
24 |
5S1 |
p. 31S-
1 p.
|
article
|
| 22 |
Human osteoblasts support human monocyte-osteoclast differentiation: evidence of prostaglandin stimulation
|
Neale, S.D
|
|
1999
|
24 |
5S1 |
p. 41S-
1 p.
|
article
|
| 23 |
Ibandronate treatment in Paget’s disease of bone
|
Grauer, A
|
|
1999
|
24 |
5S1 |
p. 87S-89S
nvt p.
|
article
|
| 24 |
Infrequent neurological manifestations in Paget’s disease of bone
|
Porrini, A.A
|
|
1999
|
24 |
5S1 |
p. 16S-
1 p.
|
article
|
| 25 |
Isolation of novel genes in Paget’s disease by subtractive hybridization
|
Dixon, J.A
|
|
1999
|
24 |
5S1 |
p. 32S-
1 p.
|
article
|
| 26 |
Israeli Arabs do have Paget’s disease of bone
|
Dolev, E
|
|
1999
|
24 |
5S1 |
p. 15S-
1 p.
|
article
|
| 27 |
Lipoprotein(a) serum levels in patients with Paget’s disease and primary hyperparathyroidism
|
Adami, S
|
|
1999
|
24 |
5S1 |
p. 32S-33S
nvt p.
|
article
|
| 28 |
Long-lasting suppression of Paget’s disease activity with cyclical tiludronate treatment
|
Ringe, J.D
|
|
1999
|
24 |
5S1 |
p. 68S-
1 p.
|
article
|
| 29 |
Long-term follow-up of Paget’s disease: progression despite medical treatment
|
Phillips, A.J
|
|
1999
|
24 |
5S1 |
p. 51S-
1 p.
|
article
|
| 30 |
Mechanisms of abnormal bone turnover in Paget’s disease
|
Roodman, G.David
|
|
1999
|
24 |
5S1 |
p. 39S-40S
nvt p.
|
article
|
| 31 |
Molecular mechanisms of action of bisphosphonates
|
Rogers, M.J
|
|
1999
|
24 |
5S1 |
p. 73S-79S
nvt p.
|
article
|
| 32 |
Paget’s disease from a genetic perspective
|
van Hul, W
|
|
1999
|
24 |
5S1 |
p. 29S-30S
nvt p.
|
article
|
| 33 |
Paget’s disease in New Zealand: Is it changing?
|
Cundy, T
|
|
1999
|
24 |
5S1 |
p. 7S-9S
nvt p.
|
article
|
| 34 |
Paget’s disease of bone: a review of 889 patients
|
Davie, M
|
|
1999
|
24 |
5S1 |
p. 11S-12S
nvt p.
|
article
|
| 35 |
Paget’s disease of bone: past and present
|
Smith, R
|
|
1999
|
24 |
5S1 |
p. 1S-2S
nvt p.
|
article
|
| 36 |
Paget’s disease of bone: remission and relapse after treatment
|
Grauer, A
|
|
1999
|
24 |
5S1 |
p. 67S-
1 p.
|
article
|
| 37 |
Paget’s disease of bone: rheumatologic complications
|
Altman, R.D
|
|
1999
|
24 |
5S1 |
p. 47S-48S
nvt p.
|
article
|
| 38 |
Paget’s disease of bone: treatment philosophy for the twenty-first century
|
Siris, E.S
|
|
1999
|
24 |
5S1 |
p. 55S-56S
nvt p.
|
article
|
| 39 |
Paget’s disease with primary hyperparathyroidism: gender distribution in 30 cases, and prediction of skeletal response to parathyroidectomy in 18
|
Gutteridge, D.H
|
|
1999
|
24 |
5S1 |
p. 51S-
1 p.
|
article
|
| 40 |
Pamidronate in acquired immune deficiency syndrome
|
Postlethwaite, A.E
|
|
1999
|
24 |
5S1 |
p. 32S-
1 p.
|
article
|
| 41 |
Pamidronate in the treatment of Paget’s disease
|
Selby, P.L
|
|
1999
|
24 |
5S1 |
p. 57S-58S
nvt p.
|
article
|
| 42 |
Pamidronate: study of two high-dose regimens in resistant Paget’s disease of bone
|
Buckler, H.M
|
|
1999
|
24 |
5S1 |
p. 67S-
1 p.
|
article
|
| 43 |
Paramyxoviruses and chronic human diseases
|
Rima, B.K
|
|
1999
|
24 |
5S1 |
p. 23S-26S
nvt p.
|
article
|
| 44 |
Paramyxoviruses and Paget’s disease: the affirmative view
|
Mee, A.P
|
|
1999
|
24 |
5S1 |
p. 19S-21S
nvt p.
|
article
|
| 45 |
Prediction and assessment of the response of Paget’s disease to bisphosphonate treatment
|
Hosking, D.J
|
|
1999
|
24 |
5S1 |
p. 69S-71S
nvt p.
|
article
|
| 46 |
Quantitative bone scintigraphy in the management of Paget’s disease of bone
|
Dońath, J
|
|
1999
|
24 |
5S1 |
p. 52S-53S
nvt p.
|
article
|
| 47 |
Severe orthopaedic complications of Paget’s disease
|
Kaplan, F.S
|
|
1999
|
24 |
5S1 |
p. 43S-46S
nvt p.
|
article
|
| 48 |
Short-term therapy with oral olpadronate in very active Paget’s disease
|
Mautalen, C
|
|
1999
|
24 |
5S1 |
p. 93S-
1 p.
|
article
|
| 49 |
Single infusion of zoledronate in Paget’s disease of bone: a placebo-controlled, dose-ranging study
|
Buckler, H
|
|
1999
|
24 |
5S1 |
p. 81S-85S
nvt p.
|
article
|
| 50 |
Surgical treatment of complications of Paget’s disease
|
Kenwright, J
|
|
1999
|
24 |
5S1 |
p. 51S-
1 p.
|
article
|
| 51 |
Thermal imaging in Paget’s disease of bone
|
Ring, E.F.J
|
|
1999
|
24 |
5S1 |
p. 53S-
1 p.
|
article
|
| 52 |
The use of risedronate in Paget’s disease
|
Miller, P.D
|
|
1999
|
24 |
5S1 |
p. 91S-92S
nvt p.
|
article
|
| 53 |
Treatment of Paget’s disease of bone with alendronate
|
Lombardi, A
|
|
1999
|
24 |
5S1 |
p. 59S-61S
nvt p.
|
article
|
| 54 |
Treatment of Paget’s disease with tiludronate
|
Fraser, W.D
|
|
1999
|
24 |
5S1 |
p. 68S-
1 p.
|
article
|
| 55 |
Urinary crosslinked N-telopeptide of type I collagen and crosslaps as markers of bone resorption in patients with Paget’s disease of bone
|
Iqbal, S.J.
|
|
1999
|
24 |
5S1 |
p. 52S-
1 p.
|
article
|
Journal description